0000950170-23-065868.txt : 20231122
0000950170-23-065868.hdr.sgml : 20231122
20231122160511
ACCESSION NUMBER: 0000950170-23-065868
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231120
FILED AS OF DATE: 20231122
DATE AS OF CHANGE: 20231122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bellon Christine
CENTRAL INDEX KEY: 0001963878
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39208
FILM NUMBER: 231433394
MAIL ADDRESS:
STREET 1: BEAM THERAPEUTICS, INC.
STREET 2: 238 MAIN STREET, 9TH FL.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Beam Therapeutics Inc.
CENTRAL INDEX KEY: 0001745999
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-327-8775
MAIL ADDRESS:
STREET 1: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
ownership.xml
4
X0508
4
2023-11-20
0001745999
Beam Therapeutics Inc.
BEAM
0001963878
Bellon Christine
C/O BEAM THERAPEUTICS INC.,
238 MAIN STREET
CAMBRIDGE
MA
02142
false
true
false
false
Chief Legal Officer
true
Common Stock
2023-11-20
4
M
false
4182
7.22
A
86584
D
Common Stock
2023-11-20
4
M
false
5818
7.22
A
92402
D
Common Stock
2023-11-20
4
S
false
5000
30.00
D
87402
D
Common Stock
2023-11-20
4
S
false
5000
31.00
D
82402
D
Stock Option (Right to Buy)
7.22
2023-11-20
4
M
false
4182
0
D
2029-05-16
Common Stock
4182
9492
D
Stock Option (Right to Buy)
7.22
2023-11-20
4
M
false
5818
0
D
2029-05-17
Common Stock
5818
10918
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.
The option vests as to 25% on the first anniversary of the vesting commencement date, May 16, 2020, and at a rate of 2.78% each month thereafter until the option is fully vested.
The option vests as to 25% on the first anniversary of the vesting commencement date, May 17, 2020, and at a rate of 2.78% each month thereafter until the option is fully vested.
By: /s/ Christine Bellon
2023-11-22